Smiths Group (LON:SMIN)‘s stock had its “buy” rating restated by equities research analysts at Deutsche Bank in a research report issued to clients and investors on Monday. They presently have a GBX 1,750 ($23.44) price objective on the stock. Deutsche Bank’s price objective indicates a potential upside of 16.90% from the company’s current price.
Other equities analysts also recently issued reports about the stock. Credit Suisse Group reiterated an “outperform” rating on shares of Smiths Group in a research note on Friday, October 13th. Numis Securities reiterated a “hold” rating and set a GBX 1,600 ($21.43) price objective on shares of Smiths Group in a research note on Monday, September 25th. reiterated a “buy” rating and set a GBX 1,900 ($25.45) price objective on shares of Smiths Group in a research note on Friday, September 29th. J P Morgan Chase & Co reiterated an “overweight” rating and set a GBX 1,800 ($24.11) price objective on shares of Smiths Group in a research note on Wednesday, November 15th. Finally, Goldman Sachs Group reiterated a “buy” rating and set a GBX 1,850 ($24.78) price objective on shares of Smiths Group in a research note on Friday, September 22nd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Smiths Group currently has an average rating of “Buy” and a consensus target price of GBX 1,754.38 ($23.50).
Smiths Group (LON SMIN) opened at GBX 1,497 ($20.05) on Monday. Smiths Group has a 1 year low of GBX 1,396 ($18.70) and a 1 year high of GBX 1,685 ($22.57).
In other news, insider George Buckley bought 1,111 shares of the stock in a transaction on Wednesday, November 1st. The stock was bought at an average cost of GBX 1,577 ($21.12) per share, for a total transaction of £17,520.47 ($23,463.87).
TRADEMARK VIOLATION WARNING: This article was posted by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://weekherald.com/2017/12/04/smiths-groups-smin-buy-rating-reaffirmed-at-deutsche-bank.html.
Smiths Group Company Profile
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
Receive News & Ratings for Smiths Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group plc and related companies with MarketBeat.com's FREE daily email newsletter.